|
DNAJC25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.32010024712326E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.23909779606402E-12 |
| Normal-vs-Stage2 |
2.659600E-03 |
| Normal-vs-Stage3 |
1.17929999998712E-06 |
| Normal-vs-Stage4 |
6.727500E-02 |
| Stage1-vs-Stage2 |
6.803700E-02 |
| Stage1-vs-Stage3 |
7.536600E-01 |
| Stage1-vs-Stage4 |
1.302180E-01 |
| Stage2-vs-Stage3 |
2.173000E-01 |
| Stage2-vs-Stage4 |
8.986000E-01 |
| Stage3-vs-Stage4 |
2.780000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.93336491050422E-12 |
| Normal-vs-AfricanAmerican |
5.38819999951201E-07 |
| Normal-vs-Asian |
6.761500E-02 |
| Caucasian-vs-AfricanAmerican |
3.633600E-01 |
| Caucasian-vs-Asian |
5.363200E-01 |
| AfricanAmerican-vs-Asian |
4.533200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.79185613200661E-13 |
| Normal-vs-Female |
6.21850000048774E-07 |
| Male-vs-Female |
3.487800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.2331000004705E-07 |
| Normal-vs-Extreme_Weight |
1.63080660087189E-12 |
| Normal-vs-Obese |
2.75040001884719E-09 |
| Normal-vs-Extreme_Obese |
3.506200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.091800E-02 |
| Normal_Weight-vs-Obese |
6.648800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.538600E-01 |
| Extreme_Weight-vs-Obese |
1.722400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.193200E-01 |
| Obese-vs-Extreme_Obese |
3.726000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.08379999986097E-07 |
| Normal-vs-Age(41-60Yrs) |
4.44470016347509E-10 |
| Normal-vs-Age(61-80Yrs) |
1.67454938804212E-12 |
| Normal-vs-Age(81-100Yrs) |
2.39349999999749E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.081600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.405000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.756200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.475820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.639800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.501800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.32940325414665E-11 |
| Normal-VS-Type2 PRCC |
7.56883444807954E-12 |
| Normal-VS-KIRP CIMP |
3.730200E-01 |
| Normal-VS-Unclassified PRCC |
2.67259999686686E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.703240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.122600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.595800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.421100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.136600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.235720E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.32629504337956E-11 |
| Normal-vs-N1 |
2.555500E-04 |
| Normal-vs-N2 |
3.626000E-01 |
| N0-vs-N1 |
1.802150E-01 |
| N0-vs-N2 |
8.034000E-01 |
| N1-vs-N2 |
9.216400E-01 |
|
|
